Lundbeck starts new study of tablet version of drug

A new phase I study will investigate how a Lundbeck drug is absorbed by the body when administered in tablet form as opposed to capsule form, which is being trialled within a number of indications.
Photo: Martin Lehmann
Photo: Martin Lehmann
BY MIKKEL AABENHUS HEMMINGSEN, TRANSLATED BY CATHERINE BRETT

Drug candidate LU AG06466 is the focus of yet another clinical trial for which Lundbeck is currently recruiting patients.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading